Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Immunologic tests: Measles virus]

Machiko Kawamura¹

¹Division of Pediatrics, Tokyo Metropolitan Komagome Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|August 23, 2005

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diffuse large B-cell lymphoma complicated by cytokine release syndrome and immune effector cell-associated neurotoxicity on day 355 of epcoritamab therapy: a case report.

Journal of clinical and experimental hematopathology : JCEH·2026

Same author

Clonal Evolution and Lineage Switch from T-Cell Acute Lymphoblastic Leukemia to Acute Myeloid Leukemia in Therapy-Resistant <i>PICALM::MLLT10</i> Leukemia.

EJHaem·2026

Same author

A Case of Diffuse Large B-Cell Lymphoma(DLBCL)Who Died of Acute Exacerbation of Interstitial Pneumonia after Treatment with R-mini-CHP in Combination with Polatuzumab Vedotin (Pola-R-mini-CHP).

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Same author

Efficacy and safety of Pola-R-mini-CHP therapy in patients aged ≥80 years with CD5-positive diffuse large B-Cell lymphoma.

Journal of clinical and experimental hematopathology : JCEH·2025

Same author

A Retrospective Study of the Efficacy and Safety of Epcoritamab in Real-world Clinical Practice: An Analysis of 19 Cases from a Single Institution.

Internal medicine (Tokyo, Japan)·2025

Same author

[Efficacy and Safety of R‒mini‒CHP Combined with Polatuzumab‒Vedotin Used for Previously Untreated Diffuse Large B‒Cell Lymphoma in Very Elderly Patients Aged ≥80 Years-A Single‒Center Retrospective Analysis].

Gan to kagaku ryoho. Cancer & chemotherapy·2025